Boyce Sarah
Avidity Biosciences Inc · President and CEO
Boyce Sarah is listed in public filings as director, officer: President and CEO. This Boyce Sarah insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Avidity Biosciences Inc (RNAM), Contineum Therapeutics, Inc. Class A Common Stock (CTNM), OmniAb, Inc. (OABIW), and OmniAb, Inc. (OABI). Investors use Boyce Sarah's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $0400k shares | OtherFeb 27, 2026 | $9.0M400k shares | $22.47 | -- | |
| $0300k shares | OtherFeb 27, 2026 | $6.7M300k shares | $22.34 | -- | |
| $0425k shares | OtherFeb 27, 2026 | $6.0M425k shares | $14.22 | -- | |
| $0165k shares | OtherFeb 27, 2026 | $5.2M165k shares | $31.42 | -- | |
| $0300k shares | OtherFeb 27, 2026 | $3.0M300k shares | $10.16 | -- | |
| $0200k shares | OtherFeb 27, 2026 | $1.3M200k shares | $6.57 | -- | |
| $0386k shares | OtherFeb 27, 2026 | $478.7K386k shares | $1.24 | -- | |
| --474.9k shares | OtherFeb 27, 2026 | Disclosure amount unavailable474.9k shares | -- | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $59k14.8k shares | Grant / ExerciseJun 26, 2025 | $59.1K14.8k shares | $4.01 | -- | |
| --20k shares | Grant / ExerciseJun 18, 2024 | Disclosure amount unavailable20k shares | -- | -- | |
| --20k shares | Grant / ExerciseJun 18, 2024 | Disclosure amount unavailable20k shares | -- | -- | |
| --20k shares | Grant / ExerciseJun 18, 2024 | Disclosure amount unavailable20k shares | -- | -- | |
| --20k shares | Grant / ExerciseJun 18, 2024 | Disclosure amount unavailable20k shares | -- | -- | |
| $168k40k shares | Grant / ExerciseJun 18, 2024 | $167.6K40k shares | $4.19 | -- | |
| $168k40k shares | Grant / ExerciseJun 18, 2024 | $167.6K40k shares | $4.19 | -- |